Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: Synthesis, characterization and biological applications

BioMetals

Volumn 26, Issue 5, 2013, Pages 741-753

  Selvamurugan, Sellappan ^a   Ramachandran, Rangasamy ^a   Viswanathamurthi, Periasamy ^a  

^a PERIYAR UNIVERSITY   (India)

Author keywords

Anticancer activity; Antioxidant; DNA cleavage; Ruthenium(II) complexes; Spectral studies

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON MONOXIDE; LIGAND; ORGANOMETALLIC COMPOUND; RUTHENIUM; SCHIFF BASE; THIOSEMICARBAZONE DERIVATIVE;

AGAR GEL ELECTROPHORESIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DNA CLEAVAGE; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; HUMAN; MCF 7 CELL LINE; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARBON MONOXIDE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA CLEAVAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, AGAR GEL; HUMANS; LIGANDS; MCF-7 CELLS; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; SCHIFF BASES; STRUCTURE-ACTIVITY RELATIONSHIP; THIOSEMICARBAZONES;

EID: 84885470940     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-013-9649-8     Document Type: Article

References (34)

1. Alagesan M, Bhuvanesh SP, Dharmaraj N (2013) Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties. Dalton Trans 42:7210-7223
2. Anitha P, Manikandan R, Endo A, Hashimoto T, Viswanathamurthi P (2012) Ruthenium(II) complexes containing quinone based ligands: Synthesis, characterization, catalytic applications and DNA interaction. Spectrochim Acta A 99:174-180
3. Atasever B, Ulkuseven B, Bal-Demirci T, Erdem-Kuruca S, Solakoǧlu Z (2010) Cytotoxic activities of new iron(III) and nickel(II) chelates of some S-methyl-thiosemicarbazones on K562 and ECV304 cells. Invest New Drugs 28:421-432
4. Bal T, Atasever B, Solakoǧlu Z, Erdem-Kuruca S, Ulküseven B (2007) Synthesis, characterisation and cytotoxic properties of the N1, N4-diarylidene-S-methyl-thiosemicarbazone chelates with Fe(III) and Ni(II). Eur J Med Chem 42(2):161-167
5. + (NS = 9-anthraldehyde thiosemicarbazones). Inorg Chem Commun 12:1094-1098
6. Blagosklonny M, EI-diery WS (1996) In vitro evaluation of a p53-expressing adenovirus as an anti-cancer drug. Int J Cancer 67:386-392
7. Da S, Maia PI, Pavan FR, Leite CQF, Lemos SS, de Sousa GF, Batista AA, Nascimento OR, Ellena J, Castellano EE, Niquet E, Deflon VM (2009) Vanadium complexes with thiosemicarbazones: synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity. Polyhedron 28:398-406
8. Demoro B, Sarniguet C, Sanchez-Delgado R, Rossi M, Liebowitz D, Caruso F, Olea-Azar C, Moreno V, Medeiros A, Comini MA, Otero L, Gambino D (2012) New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents. Dalton Trans 41(5):1534-1543
9. Fricker SP (2007) Metal based drugs: from serendipity to design. Dalton Trans 43:4903-4917
10. Fry NL, Mascharak PK (2011) Photoactive ruthenium nitrosyls as NO donors: how to sensitize them toward visible light. Acc Chem Res 44:289-298
11. Gulcin I, Kufrevioglu OI, Oktay M, Buyukokuroglu ME (2004) Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.). J Ethnopharmacol 90:205-215
12. Hanson K, Wilger DJ, Jones ST, Harrison DP, Bettis SE, Luo H, Papanikolas JM, Waters ML, Meyer TJ (2013) Electron transfer dynamics of peptide-derivatized RuII-polypyridyl complexes on nanocrystalline metal oxide films. Pept Sci 100:25-37
13. Hartinger CG, Dyson PJ (2009) Bioorganometallic chemistry-from teaching paradigms to medicinal applications. Chem Soc Rev 38:391-401
14. Hsu CW, Kuo CF, Chuang SM, Hou MH (2013) Elucidation of the DNA-interacting properties and anticancer activity of a Ni (II)-coordinated mithramycin dimer complex. Biometals 26:1-12
15. 12] complex in cancer: preliminary tests. Anticancer Res 22:1713
16. Kalaivani P, Prabhakaran R, Poornima P, Dallemer F, Vijayalakshmi K, Vijaya Padma V, Natarajan K (2012) Versatile coordination behavior of salicylaldehyde thiosemicarbazone in ruthenium(II) carbonyl complexes: synthesis, spectral, X-ray, electrochemistry, DNA binding, cytotoxicity, and cellular uptake Studies. Organometallics 31:8323-8332
17. Ma ZY, Qiao X, Xie CZ, Shao J, Xu JY, Qiang ZY, Lou JS (2012) Activities of a novel Schiff base copper(II) complex on growth inhibition and apoptosis induction toward MCF-7 human breast cancer cells via mitochondrial pathway. J Inorg Biochem 117:1-9
18. Muthu Tamizh M, Mereiter K, Kirchner K, Karvembu K (2012) Ruthenium(II) carbonyl complexes containing pincer like ONS donor Schiff base and triphenylphosphine as catalyst for selective oxidation of alcohols at room temperature. J Organomet Chem 700:194-201
19. Narayana Prabhu R, Ramesh R (2012) Synthesis, structural characterization, electrochemistry and catalytic transfer hydrogenation of ruthenium(II) carbonyl complexes containing tridentate benzoylhydrazone ligands. J Organomet Chem 718:43-51
20. 2O donors. Polyhedron 24:1885-1892
21. 2 spheres assembled via pyridine-imine-amide coordination. Syntheses, structures, properties and protonation behaviour of coordinated amide. J Chem Soc Dalton Trans. doi: 10.1039/B110912J
22. Ramachandran R, Viswanathamurthi P (2013) Ruthenium(II) carbonyl complexes containing pyridine carboxamide ligands and PPh3/AsPh3/Py coligands: synthesis, spectral characterization, catalytic and antioxidant studies. Spectrochim Acta A 103:53-61
23. Ramachandran E, Thomas SP, Poornima P, Kalaivani P, Prabhakaran R, Vijaya Padma V, Natarajan K (2012) Evaluation of DNA binding, antioxidant and cytotoxic activity of mononuclear Co(III) complexes of 2-oxo-1,2-dihydrobenzo[h] quinoline-3-carbaldehyde thiosemicarbazones. Eur J Med Chem 50:405-415
24. Rice-Evans CA, Diplock AT (1993) Current status of antioxidant therapy. Free Radic Biol Med 15:77-96
25. 3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro. Dalton Trans 41:2066-2077
26. Sathyadevi P, Krishnamoorthy P, Bhuvanesh SP, Kalaiselvi P, Vijaya Padma V, Dharmaraj N (2012) Organometallic ruthenium(II) complexes: Synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity. Eur J Med Chem 55:420-431
27. Senthil Raja D, Bhuvanesh SP, Natarajan K (2011) Biological evaluation of a novel water soluble sulphur bridged binuclear copper(II) thiosemicarbazone complex. Eur J Med Chem 46:4584-4594
28. Stringer T, Therrien B, Hendricks DT, Guzgav H, Smith GS (2011) Mono- and di-nuclear (η6-arene) ruthenium(II) benzaldehyde thiosemicarbazone complexes: Synthesis, characterization and cytotoxicity. Inorg Chem Commun 14(6):956-960
29. Su W, Zhou Q, Huang Y, Huang Q, Huo L, Xiao Q, Huang S, Huang C, Chen R, Qian Q, Liu L, Li P (2013) Synthesis, crystal and electronic structure, anticancer activity of ruthenium(II) arene complexes with thiosemicarbazones. Appl Organomet Chem 27:307-312
30. Tsai K, Hsu TG, Hsu KM, Cheng H, Liu TY, Hsu CF, Kong CW (2001) Oxidative DNA damage in human peripheral leukocytes induced by massive aerobic exercise. Free Radic Biol Med 31:1465-1472
31. Udilova N, Kozlov AV, Bieberschulte W, Frei K, Ehrenberger K, Nohl H (2003) The antioxidant activity of caroverine. Biochem Pharmacol 65:59-65
32. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307-320
33. Wang BD, Yang ZY, Lu MH, Hai J, Wang Q, Chen ZN (2009) Synthesis, characterization, cytotoxic activity and DNA binding Ni(II) complex with the 6-hydroxy chromone-3-carbaldehyde thiosemicarbazone. J Organomet Chem 694:4069-4075
34. Xie YY, Huang HL, Yao JH, Lin GJ, Jiang GB, Liu YJ (2013) DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes. Eur J Med Chem 63:603-610